Legend Biotech Revenue 2019-2021 | LEGN

Legend Biotech annual/quarterly revenue history and growth rate from 2019 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Legend Biotech revenue for the quarter ending September 30, 2021 was $0.017B, a 31.53% increase year-over-year.
  • Legend Biotech revenue for the twelve months ending September 30, 2021 was $0.095B, a 59.64% increase year-over-year.
  • Legend Biotech annual revenue for 2020 was $0.082B, a 27.03% increase from 2019.
  • Legend Biotech annual revenue for 2019 was $0.064B, a 2.15% increase from 2018.
  • Legend Biotech annual revenue for 2018 was $0.063B, a INF% increase from .
Legend Biotech Annual Revenue
(Millions of US $)
2020 $82
2019 $64
2018 $63
Legend Biotech Quarterly Revenue
(Millions of US $)
2021-09-30 $17
2021-06-30 $22
2021-03-31 $14
2020-12-31 $42
2020-09-30 $13
2020-06-30 $13
2020-03-31 $14
2019-12-31 $20
2019-09-30 $21
2019-06-30 $11
2019-03-31 $13
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.389B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69